TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
-3.25%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.29B
AUM Growth
-$158M
(-6.5%)
Cap. Flow
-$50.3M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
41.8%
Holding
210
New
13
Increased
53
Reduced
56
Closed
18
Top Buys
| 1 |
Merck
MRK
|
$16.6M |
| 2 |
Illumina
ILMN
|
$13M |
| 3 |
Humana
HUM
|
$9.23M |
| 4 |
Biogen
BIIB
|
$7.74M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.28M |
Top Sells
| 1 |
Amgen
AMGN
|
$18.8M |
| 2 |
Abbott
ABT
|
$15.2M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$15M |
| 4 |
Thermo Fisher Scientific
TMO
|
$13.7M |
| 5 |
Eli Lilly
LLY
|
$10.8M |
Sector Composition
| 1 | Healthcare | 94.94% |
| 2 | Real Estate | 3.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Alkermes
ALKS
$4.77B
| $3.86M | 0.17% |
198,048
| – | – |
|
102
Bausch Health
BHC
$2.67B
| $3.69M | 0.16% |
168,812
| – | – |
|
103
Medical Properties Trust
MPW
$2.67B
| $3.66M | 0.16% |
187,063
| – | – |
|
104
Takeda Pharmaceutical
TAK
$48.3B
| $3.62M | 0.16% |
210,146
+32,018
| +18% | +$551K |
|
105
Steris
STE
$24B
| $3.54M | 0.15% |
24,473
-4,508
| -16% | -$651K |
|
|
XLRN
106
DELISTED
Acceleron Pharma Inc.
XLRN
| $3.41M | 0.15% |
86,313
-102,075
| -54% | -$4.03M |
|
|
AVDL
107
Avadel Pharmaceuticals
AVDL
$1.46B
| $3.39M | 0.15% |
814,588
| – | – |
|
108
Editas Medicine
EDIT
$227M
| $3.36M | 0.15% |
147,939
+102,950
| +229% | +$2.34M |
|
109
Charles River Laboratories
CRL
$7.99B
| $3.32M | 0.14% |
25,067
+10,900
| +77% | +$1.44M |
|
|
DHC
110
Diversified Healthcare Trust
DHC
$939M
| $3.31M | 0.14% |
357,720
| – | – |
|
111
Alcon
ALC
$39B
| $3.23M | 0.14% |
55,369
| – | – |
|
112
Iovance Biotherapeutics
IOVA
$796M
| $3.19M | 0.14% |
175,012
-24,061
| -12% | -$438K |
|
113
Tenet Healthcare
THC
$17B
| $3.12M | 0.14% |
141,136
-41,535
| -23% | -$919K |
|
|
PTLA
114
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.1M | 0.14% |
115,448
| – | – |
|
115
Inogen
INGN
$220M
| $2.95M | 0.13% |
61,526
+47,526
| +339% | +$2.28M |
|
116
Insmed
INSM
$30.1B
| $2.91M | 0.13% |
+164,786
| New | +$2.91M |
|
117
Quest Diagnostics
DGX
$20.1B
| $2.78M | 0.12% |
26,012
| – | – |
|
118
Cardinal Health
CAH
$35.7B
| $2.75M | 0.12% |
58,241
+51,941
| +824% | +$2.45M |
|
119
Ardelyx
ARDX
$1.58B
| $2.74M | 0.12% |
582,698
-56,672
| -9% | -$266K |
|
120
Agilent Technologies
A
$36.4B
| $2.61M | 0.11% |
34,025
+425
| +1% | +$32.6K |
|
121
Fate Therapeutics
FATE
$112M
| $2.57M | 0.11% |
165,672
+141,293
| +580% | +$2.19M |
|
|
WMGI
122
DELISTED
Wright Medical Group Inc
WMGI
| $2.56M | 0.11% |
124,006
+55,500
| +81% | +$1.14M |
|
123
Pacific Biosciences
PACB
$372M
| $2.56M | 0.11% |
+495,495
| New | +$2.56M |
|
124
Amicus Therapeutics
FOLD
$2.47B
| $2.52M | 0.11% |
314,597
| – | – |
|
125
Wave Life Sciences
WVE
$1.3B
| $2.52M | 0.11% |
122,551
+66,596
| +119% | +$1.37M |
|